BrainsWay Ltd. (NASDAQ: BWAY)
$7.10
+0.2000 ( +2.90% ) 18.1K
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
Market Data
Open
$7.10
Previous close
$6.90
Volume
18.1K
Market cap
$119.17M
Day range
$6.25 - $7.15
52 week range
$2.17 - $7.62
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 2 | Mar 06, 2024 |
6-k | Quarterly Reports | 2 | Jan 10, 2024 |
6-k | Quarterly Reports | 2 | Dec 19, 2023 |
6-k | Quarterly Reports | 2 | Nov 20, 2023 |
6-k | Quarterly Reports | 2 | Nov 15, 2023 |
6-k | Quarterly Reports | 2 | Nov 02, 2023 |
6-k | Quarterly Reports | 2 | Oct 16, 2023 |
6-k | Quarterly Reports | 2 | Sep 20, 2023 |
6-k | Quarterly Reports | 2 | Sep 05, 2023 |
6-k | Quarterly Reports | 2 | Aug 23, 2023 |